New daily pill aids weight loss for people with obesity and type 2 diabetes

medicalxpress.com

A daily pill demonstrated significant weight loss, helping individuals shed approximately 10% of their body weight over 18 months. The study, published in The Lancet, tested Eli Lilly's oral drug orforglipron in over 1,500 adults with obesity and type 2 diabetes, showing comparable results to injectable GLP-1 agonists. This new pill, expected to be cheaper and easier to administer, could offer a more accessible treatment option for obesity, a growing global health concern.


With a significance score of 6.1, this news ranks in the top 0.2% of today's 29749 analyzed articles.

Get summaries of news with significance over 5.5 (usually ~10 stories per week). Read by 10,000+ subscribers: